gimli
COHANCE stock analysis context
COHANCE LIFESCIENCES Stock Context for AI Screening
COHANCE LIFESCIENCES LTD is a mid-cap stock in Healthcare. This page summarizes key screening signals for COHANCE LIFESCIENCES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about COHANCEPrice
₹418.55
1M return
+15.33%
3M return
+37.05%
Market cap
₹16,012.35 cr
PE
89.37
ROE
+9.21%
RSI
49.12
Turnover
₹19.30 cr
Why it can matter in screens
- Momentum: COHANCE is above 50DMA; RSI is 49.12.
- Returns: 1M +15.33%, 3M +37.05%, 6M -28.98%.
- Liquidity: latest turnover is ₹19.30 cr.
- Valuation: PE 89.37, PB 3.97, ROE +9.21%, ROCE +11.54%.
- Growth: 3Y sales CAGR -3.56%, 3Y profit CAGR -16.11%.
Try these prompts
- Analyze COHANCE LIFESCIENCES with valuation, momentum and industry peers
- Compare COHANCE with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare COHANCE with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.